Hypothalamic abnormalities and Parkinsonism associated with H1N1 influenza infection by González-Duarte, Alejandra et al.
CASE REPORT Open Access
Hypothalamic abnormalities and Parkinsonism
associated with H1N1 influenza infection
Alejandra González-Duarte
*, Lucía Magaña Zamora, Carlos Cantú Brito, Guillermo García-Ramos
Abstract
Objective: To describe a case of a young adult with severe H1N1 influenza illness associated with hypothalamic
abnormalities and post-influenza parkinsonism.
Design: Case report.
Patient: A 22-year-old woman with H1N1 influenza infection developed encephalopathy followed by diverse
hypothalamic dysfunction manifestations, sleeplessness, and persistent parkinsonian features.
Results: CSF analysis, brain imaging and EEG ruled out hypoxic brain injury or other illnesses.
Conclusions: A number of viruses have been associated with both acute and chronic parkinsonism. A link
between parkinsonism and influenza viruses is somewhat controversial. This is the first reported case of
parkinsonism following an H1N1 influenza infection.
Background
The full incidence of neurologic complications and
sequelae from the 2009 influenza A (H1N1) pandemic
has yet to be determined. There is a large body of evi-
dence that influenza can directly lead to encephalitis;
however, a link with Parkinson’s disease is somewhat
controversial [1]. Many of the influenza viruses have not
demonstrated clear neurotropism, and they rarely pro-
duce a true neuroinvasive disease. For this reason, a
possible connection between postencephalic Parkinson’s
disease and influenza is based only on simultaneous
occurrence. The recognition of neurologic post-influen-
zal disease has been based on coincidental occurrence
with influenza pandemics, and to date there are no diag-
nostic serological, animal or electrographical confirma-
tion tests. In 1974, Gamboa et al [2] found antigen
material related to neurotropic influenza strain A0 in
some neurons of the hypothalamus and substantia nigra
in postencephalitic parkinsonian brains. Other reports
have also found Influenza viral RNA in cerebrospinal
fluid [3,4]. However, these findings have not been con-
sistent. Moreover, the failure to demonstrate differences
in influenza virus H1 antibodies between postencephalic
Parkinson patients and idiopathic Parkinson patients,
carefully matched many years after the epidemic, weighs
against the persistence of influenza virus in postence-
phalic Parkinson patients [5] and its possible pathogenic
role.
In recent years, many cases of influenza-associated
acute encephalopathy have continued to emerge [5-9].
The question arises as to whether there is any evidence
that points to a relationship between the virus and the
concurrently neurologic emergent disease. We describe
a patient with parkinsonian neurologic complications
associated with severe H1N1 influenza infection.
Case summary
A previously healthy 22-year-old Hispanic female was
admitted to a local hospital after two weeks of fever of
39.5°C (103.1°F), non-productive cough, dyspnea and
cyanosis. Community acquired pneumonia or influenza
H1N1 was suspected, and treatment with clarithromy-
cin, ceftriaxone and oseltamivir was initiated. She
required intubation and mechanical ventilation, and was
referred to our institution.
Upon her arrival, she was moderately agitated despite
sedation. Her blood pressure was130/90 mmHg, with a
heart rate of 100 beats per minute, a temperature of
37°C and an O2 saturation of 80%. Her WBC was
13,500 cel/mm
3, with 86% neutrophils and 7.9%
* Correspondence: gonzalezduarte@aol.com
Department of Neurology, Instituto Nacional de Ciencias Médicas y Nutrición
Salvador Zubirán, México D.F., México




© 2010 González-Duarte et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.lymphocytes; serum glucose was 129 mg/dL, sodium
132 mEq/L, and creatinine 0.49 mg/dL. A thoracic CT
scan showed bilateral infiltrates consistent with pneu-
monia. Ceftriaxone treatment was changed to piperazil-
lin and tazobactam, while treatment with clarithromycin
and oseltamivir was continued. She also received aman-
tadine for 3 days, but this was discontinued after detec-
tion of H1N1 influenza RNA by RT-PCR (CDC
Realtime rTPCR, dual-labeled hydrolyisis TaqMan®
probes, 2009 CDC protocol for detection and characteri-
zation of swine influenza) in a nasopharyngeal swab.
Over the following days, her sodium levels increased
to 151 mEq/L despite treatment with free water. As
the urine osmolality was persistently low, diabetes insi-
pidus was suspected, and intranasal desmopressin was
initiated. Twenty days later she was extubated. While
fentanyl and midazolam were being titrated down, she
became severely agitated and was treated with haloper-
idol. Around that time a generalized resting tremor
was noted, predominately on the left leg and left arm,
as well as masked face, decreased blinking, and cog-
wheel phenomena. She did not have elevated tempera-
ture or elevation of serum CPK levels. Haloperidol was
discontinued, but the tremor did not subside. EEG
and brain MRI were normal; specifically, there were
no signs of pontine myelinolysis or basal ganglia
abnormalities. CSF analysis was normal, with 0 cells/
mm
3, protein 39 mg/dL and glucose 47 mg/dL (serum
glucose 75 mg/dL). Seven days later she developed
severe autonomic cardiovascular fluctuations consistent
with bouts of hypertension alternated with hypoten-
sion, brady and tachyarrhythmias. Her blood pressure
ranged from 160/100 mmHg to 80/40 mmHg and her
heart rate ranged from 180 beats per minute to 35
beats per minute (Figure 1). Soon after clonidine was
started, her heart rate and blood pressure became
stable.
Six months later she still complains of diurnal somno-
lence, insomnia and hyperhidrosis. She is alert and
answers questions appropriately, although her behavior
is disinhibited at times. Cranial nerve examination is
normal. Muscle strength is 3/5 in upper and lower
extremities, and there is muscle atrophy. Deep tendon
reflexes are globally diminished. Plantar reflexes are
flexor. She displays parkinsonian features despite the use
of biperiden and clonazepam (Additional file 1).
Discussion
We describe psychomotor agitation at onset, several
hypothalamic abnormalities, sleeplessness and changes
in conduct occurring in an otherwise healthy young
adult with H1N1 influenza infection. The findings of
Figure 1 Blood pressure and heart rate changes. (A) Five days after norepinephrine infusion was stopped, the patient was stable and was
weaned off the ventilator; (B) and (C) heart rate and blood pressure show random elevations, the patient was afebrile; (D) after initiating
clonidine the vital signs were more stable. BP: blood pressure, HR: heart rate, BPM: beats per minute.
González-Duarte et al. Journal of Neuroinflammation 2010, 7:47
http://www.jneuroinflammation.com/content/7/1/47
Page 2 of 4neurogenic deficiency of arginine-vasopressin (AVP),
autonomic hyperactivity, loss of the circadian rhythm,
behavioral inappropriateness, and hyperhidrosis support
the involvement of the hypothalamus. The patient still
displays post-encephalic parkinsonian motor symptoms
consistent of bradykinesia, tremor and “mask like” face
months after the acute illness.
Paroxysmal autonomic instability has been associated
with encephalitis among other intracranial catastrophes.
It consists of severe blood pressure fluctuations with
wide pulse pressure, tachyarrhythmias, hyperthermia
and hyperhidrosis [10] with or without dystonia [11].
This dramatic response reflects direct excitation, disinhi-
bition, or both, of sympathoexcitatory areas of the
hypothalamus or the medulla [10]. Neurogenic pulmon-
ary edema, neurocardiogenic injury, cardiac arrhythmias,
and sudden death are among the most dreaded possible
complications [10]. Neuroleptic malignant syndrome
(NMS) is a severe idiosyncratic reaction resulting from
impaired central dopaminergic transmission in the
hypothalamus and basal ganglia. Two common triggers
are drug-induced blockade of D2-dopaminergic recep-
tors and sudden withdrawal of dopaminergic agonists.
While the use of haloperidol and amantadine withdrawal
have been linked to NMS, the lack of full recovery and
the absence of CPK elevations does not support NMS in
our patient.
Neurologic complications of the influenza virus are
uncommon complications of a very common infection.
The pathogenesis is still not fully understood. The
absence of a significant inflammatory response in the
CSF supports para-infectious or post-infectious immune
mechanisms. The hypothalamus coordinates many com-
plex patterns of neuroendocrine outputs, circadian
rhythms, homeostatic mechanisms and behavior.
Although acute hypothalamic-pituitary-adrenal axis
responses to stress are generally adaptive, excessive
responses can lead to deleterious effects. Specialized
brain regions that lack an effective blood-brain barrier
include the hypothalamus and circumventricular areas.
The capillary endothelium is fenestrated to allow free
passage of large proteins and other molecules. These
structures are densely vascularized and may be the site
of action of interleukins to elicit both fever and ACTH
secretion. Several studies have proposed a central role
for various inflammatory cytokines in the genesis of
influenza-associated neurologic illness [9]. Rather than a
direct neuroinvasion, it is possible that the hypothala-
mus and surrounding structures are vulnerable to the
massive cytokinemia produced in patients with more
severe forms of influenza. However, it is also likely that
a spectrum of illnesses or underlying factors is at play,
and more research needs to be done.
Sporadic cases clinically diagnosed as H1N1-associated
neurologic complications attract close attention, not just
as a matter of historical curiosity, but as observational
evidence to obtain objective data. The severity of neuro-
logic sequelae warrant efforts to investigate these spora-
dic cases to better understand various chronic
neurologic conditions, especially parkinsonism.
In summary, our patient displays several hypothalamic
abnormalities and post-encephalic parkinsonian features.
The exclusion of other possible etiologies of acute neu-
rologic illness, combined with supportive evidence of
acute influenza virus infection, suggests that these are
influenza-associated complications. Case reports like
ours highlight the threat of CNS involvement. Although
rare, these neurologic manifestations may be overlooked
in patients with H1N1 influenza.
Additional material
Additional File 1: Video 1 3GPP movie Video 1 showing persistent
unilateral tremor. The patient displays an involuntary oscillating
rhythmic tremor in her left arm that is present at rest, although it is
better visualized for video purposes while she is stretching her arms. A
masked face is also present. These features were not present before her
hospital stay.
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